Highly expressed CD7 in T‐ALL blasts, including ETP‐ALL, is considered a better target for ETP‐ALL,[5] and many preclinical studies[19, 20, 21] and clinical trials[10] of CD7 CAR‐T cells for T‐ALL are ongoing. Here, CD7 is linked to acute lymphoblastic leukemia.